Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction

被引:66
|
作者
Shimizu, Shuya
Naitoh, Itaru [1 ]
Nakazawa, Takahiro
Hayashi, Kazuki
Miyabe, Katsuyuki
Kondo, Hiromu
Yoshida, Michihiro
Yamashita, Hiroaki
Umemura, Shuichiro
Hori, Yasuki
Ohara, Hirotaka [2 ]
Joh, Takashi
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan
关键词
cholecystitis; distal malignant biliary obstruction; pancreatitis; self-expandable metal stent; HIGH-RISK PATIENTS; COMMON BILE-DUCT; RANDOMIZED-TRIAL; PLACEMENT; WALLSTENT; MANAGEMENT; DRAINAGE;
D O I
10.1111/j.1440-1746.2012.07283.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: Pancreatitis and cholecystitis are major complications after self-expandable metal stent (SEMS) placement in distal malignant biliary obstruction. We aimed to clarify predictive factors for pancreatitis and cholecystitis after covered SEMS placement. Methods: We retrospectively reviewed 74 consecutive patients with distal malignant biliary obstruction who underwent initial endoscopic drainage using covered SEMS. Predictive factors for pancreatitis and cholecystitis were evaluated in the 74 patients described above and in 66 patients who had not undergone cholecystectomy. Results: The incidences of pancreatitis and cholecystitis were 10.8% (8/74) and 6.1% (4/66), respectively. Univariate analysis revealed that non-pancreatic cancer (P = 0.018) and contrast injection into the pancreatic duct (P = 0.030) were significant predictive factors for pancreatitis. Multivariate analysis revealed that non-pancreatic cancer (odds ratio [OR], 4.21; 95% confidence interval [CI], 1.63-14.18; P = 0.007) and contrast injection into the pancreatic duct (OR, 3.34; 95% CI, 1.33-9.60; P = 0.016) were significant independent predictive factors for pancreatitis. On the other hand, univariate and multivariate analyses revealed that tumor involvement to the orifice of the cystic duct (OCD) was a significant independent predictive factor for cholecystitis (OR, 5.85; 95% CI, 1.91-27.74; P = 0.005). Conclusions: Non-pancreatic cancer and contrast injection into the pancreatic duct were predictive factors for pancreatitis, and tumor involvement to the OCD was a positive predictive factor for cholecystitis after endoscopic covered SEMS placement for distal malignant biliary obstruction.
引用
收藏
页码:68 / 72
页数:5
相关论文
共 50 条
  • [1] Predictive factors for pancreatitis and cholecystitis in endoscopic covered self-expandable metallic stent placement for distal malignant biliary obstruction
    Toyohara, Tadashi
    Watanabe, Takashi
    Uno, Konomu
    Suzuki, Takanori
    Kanda, Takeo
    Araki, Hiromichi
    Suzuki, Yuka
    Nagao, Kazuhiro
    Mizuno, Yusuke
    Kusakabe, Atsunori
    Kanie, Hiroshi
    Shimizu, Syuya
    Yamada, Tomonori
    Hayashi, Katsumi
    Nakazawa, Takahiro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 246 - 246
  • [2] PROPHYLACTIC ENDOSCOPIC GALLBLADDER STENTING FOR THE CHOLECYSTITIS AFTER COVERED METAL STENT PLACEMENT FOR DISTAL BILIARY OBSTRUCTION
    Ishii, Tatsuya
    Kin, Toshifumi
    Toyonaga, Haruka
    Hayashi, Tsuyoshi
    Takahashi, Kuniyuki
    Katanuma, Akio
    GASTROINTESTINAL ENDOSCOPY, 2022, 95 (06) : AB291 - AB292
  • [3] Risk Factors for Pancreatitis and Cholecystitis after Endoscopic Biliary Stenting in Patients with Malignant Extrahepatic Bile Duct Obstruction
    Kim, Ga Hee
    Ryoo, Si Kyong
    Park, Jae Keun
    Park, Joo Kyung
    Lee, Kwang Hyuck
    Lee, Kyu Taek
    Lee, Jong Kyun
    CLINICAL ENDOSCOPY, 2019, 52 (06) : 598 - 605
  • [4] Feasibility of one-step endoscopic metal stenting for distal malignant biliary obstruction
    Shimizu, Shuya
    Naitoh, Itaru
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Miyabe, Katsuyuki
    Kondo, Hiromu
    Yoshida, Michihiro
    Yamashita, Hiroaki
    Ohara, Hirotaka
    Joh, Takashi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (03) : 219 - 225
  • [5] ENDOSCOPIC STENTING FOR MALIGNANT BILIARY OBSTRUCTION
    CHEUNG, KL
    LAI, ECS
    ARCHIVES OF SURGERY, 1995, 130 (02) : 204 - 207
  • [6] Endoscopic Stenting for Malignant Biliary Obstruction
    Edward C.S. Lai
    Chung-Mau Lo
    Chee-Leung Liu
    World Journal of Surgery, 2001, 25 : 1289 - 1295
  • [7] Endoscopic stenting for malignant biliary obstruction
    Lai, ECS
    Lo, CM
    Liu, CL
    WORLD JOURNAL OF SURGERY, 2001, 25 (10) : 1289 - 1295
  • [8] Risk factors for early and late cholecystitis after covered metal stent placement for distal biliary obstruction
    Ishii, Tatsuya
    Hayashi, Tsuyoshi
    Yamazaki, Hajime
    Nakamura, Risa
    Iwano, Kosuke
    Ando, Ryo
    Toyonaga, Haruka
    Kin, Toshifumi
    Takahashi, Kuniyuki
    Katanuma, Akio
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2023, 30 (10) : 1180 - 1187
  • [9] Covered Metal Stenting for Malignant Lower Biliary Stricture with Pancreatic Duct Obstruction: Is Endoscopic Sphincterotomy Needed?
    Nakahara, Kazunari
    Okuse, Chiaki
    Suetani, Keigo
    Michikawa, Yosuke
    Kobayashi, Shinjiro
    Otsubo, Takehito
    Itoh, Fumio
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [10] Risk factors for acute pancreatitis post percutaneous transhepatic biliary stenting in patients with distal malignant obstruction
    Zhang, Chengzhi
    Liu, Yiming
    Zhou, Xueliang
    Sun, Zhanguo
    Li, Yipu
    Hou, Rongna
    Han, Xinwei
    Jiao, Dechao
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2024, 14 (09) : 6508 - 6516